Literature DB >> 29129678

Pathophysiological mechanisms of migraine and epilepsy: Similarities and differences.

Massimo Mantegazza1, Sandrine Cestèle2.   

Abstract

Migraine and epilepsy are episodic disorders with distinct features, but they have some clinical and pathophysiological overlaps. We review here clinical overlaps between seizures and migraine attacks, activities of neuronal networks observed during seizures and migraine attacks, and molecular and cellular mechanisms of migraine identified in genetic forms, focusing on genetic variants identified in hemiplegic migraine and their functional effects. Epilepsy and migraine can be generated by dysfunctions of the same neuronal networks, but these dysfunctions can be disease-specific, even if pathogenic mutations target the same protein. Studies of rare monogenic forms have allowed the identification of some molecular/cellular dysfunctions that provide a window on pathological mechanisms: we have begun to disclose the tip of the iceberg.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cortical spreading depression; Depolarizing block; Excitability; FHM; Mutation; Seizures

Mesh:

Substances:

Year:  2017        PMID: 29129678     DOI: 10.1016/j.neulet.2017.11.025

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Modeling cortical spreading depression induced by the hyperactivity of interneurons.

Authors:  Mathieu Desroches; Olivier Faugeras; Martin Krupa; Massimo Mantegazza
Journal:  J Comput Neurosci       Date:  2019-10-17       Impact factor: 1.621

2.  A 5-HT1D -receptor agonist protects Dravet syndrome mice from seizure and early death.

Authors:  Paul G Hatini; Kathryn G Commons
Journal:  Eur J Neurosci       Date:  2020-06-25       Impact factor: 3.386

Review 3.  Epilepsy and Migraine Shared Genetic and Molecular Mechanisms: Focus on Therapeutic Strategies.

Authors:  Palvi Gotra; Nidhi Bhardwaj; Abhilash Ludhiadch; Gagandeep Singh; Anjana Munshi
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

Review 4.  Sodium channelopathies of skeletal muscle and brain.

Authors:  Massimo Mantegazza; Sandrine Cestèle; William A Catterall
Journal:  Physiol Rev       Date:  2021-03-26       Impact factor: 46.500

5.  Headache in epilepsy: A prospective observational study.

Authors:  Mark A Whealy; Anna Myburgh; Tanya J Bredesen; Jeffrey W Britton
Journal:  Epilepsia Open       Date:  2019-10-21

6.  Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study.

Authors:  Cecilia Rustichelli; Elisa Bellei; Stefania Bergamini; Emanuela Monari; Carlo Baraldi; Flavia Lo Castro; Aldo Tomasi; Anna Ferrari
Journal:  Cephalalgia       Date:  2020-06-26       Impact factor: 6.292

Review 7.  Migraine and neuroinflammation: the inflammasome perspective.

Authors:  Oguzhan Kursun; Muge Yemisci; Arn M J M van den Maagdenberg; Hulya Karatas
Journal:  J Headache Pain       Date:  2021-06-10       Impact factor: 7.277

8.  Gain of Function for the SCN1A/hNav1.1-L1670W Mutation Responsible for Familial Hemiplegic Migraine.

Authors:  Sandra Dhifallah; Eric Lancaster; Shana Merrill; Nathalie Leroudier; Massimo Mantegazza; Sandrine Cestèle
Journal:  Front Mol Neurosci       Date:  2018-07-09       Impact factor: 5.639

9.  Ca2+ Signals in Astrocytes Facilitate Spread of Epileptiform Activity.

Authors:  Kjell Heuser; Cecilie G Nome; Klas H Pettersen; Knut S Åbjørsbråten; Vidar Jensen; Wannan Tang; Rolf Sprengel; Erik Taubøll; Erlend A Nagelhus; Rune Enger
Journal:  Cereb Cortex       Date:  2018-11-01       Impact factor: 5.357

10.  Modeling NaV1.1/SCN1A sodium channel mutations in a microcircuit with realistic ion concentration dynamics suggests differential GABAergic mechanisms leading to hyperexcitability in epilepsy and hemiplegic migraine.

Authors:  Louisiane Lemaire; Mathieu Desroches; Martin Krupa; Lara Pizzamiglio; Paolo Scalmani; Massimo Mantegazza
Journal:  PLoS Comput Biol       Date:  2021-07-27       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.